Projects

doc. MUDr. Žofia Rádiková, PhD.

International

Current
  • European partnership fostering a European Research Area (ERA) for health research
    Program: Horizon Europe
    Duration: 1. 11. 2022 – 30. 10. 2029

National

Current
  • Effects of GLP-1 Analog on Multiple Sclerosis
    Program: SRDA
    Duration: 1. 7. 2022 – 30. 6. 2026
  • Testing the effectiveness of polygenic risk score calculations from whole genome sequencing data and evaluation of hereditary patterns of polygenic diseases
    Program: VEGA
    Duration: 1. 1. 2023 – 31. 12. 2025
Finished
  • Hepatic, lipid and cardiometabolic parameters changes in obese patients
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2023
  • Effect of physical activity and nutrition on gut microbiota modification in healthy subjects and patients with a non - communicable diseases
    Program: SRDA
    Duration: 1. 8. 2018 – 30. 6. 2022
  • Immune response to SARS-CoV-2 infection and development of clinically relevant virological tests to improve the management of the COVID-19 pandemic
    Program: SRDA
    Duration: 16. 9. 2020 – 31. 12. 2021
  • The role of myokines and adipokines in improvement of the cardiometabolic parameters following lifestyle changes in sedentary subjects
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2020
  • Single Nucleotide Polymorphism C1858T in PTPN22 Gene in Slovak Population of Patients with Rheumatoid Arthritis
    Program: VEGA
    Duration: 1. 1. 2009 – 1. 12. 2011
  • Development of endocrine and metabolic risk factors in young patients with essential hypertension in relation to applied therapy
    Program: VEGA
    Duration: 1. 1. 2007 – 1. 12. 2009
  • Adrenal gland and sympathetic nervous system in the in the pathogenesis of rheumatic diseases
    Program: VEGA
    Duration: 1. 1. 2006 – 1. 12. 2008
Employees